lisdexamfetamine dimesylate 20 MG [Vyvanse]

RxNorm concept 854831, branded drug component (sbdc).

RxCUI: 854831
Term type: Branded drug component (SBDC)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/854831 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

lisdexamfetamine 700810

Related concepts

lisdexamfetamine dimesylate 20 MG Oral Capsule [Vyvanse] (SBD, constitutes)
lisdexamfetamine dimesylate 20 MG Chewable Tablet [Vyvanse] (SBD, constitutes)
Vyvanse (BN, has ingredient)
lisdexamfetamine dimesylate 20 MG (SCDC, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 854831 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/854831 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 854831. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.